Pfizer and IIT Delhi Announce the 'Innovation & IP Program' to Help Create Healthcare Innovations in India

Pfizer together with IIT Delhi today announced the launch of ‘The Pfizer IIT-Delhi Innovation and IP Program’, an incubation accelerator initiative co-created by Pfizer and the Foundation for Innovation and Technology Transfer (FITT) at the Indian Institute of Technology, Delhi (IIT-Delhi). The Program will be open to Indian nationals - individuals and startup companies – and comprises two components. For innovators seeking comprehensive support to translate their healthcare ideas into patents, the program will provide two years of residential incubation at IIT Delhi, funding of up to Rs. 50 lacs for each innovator, mentoring support from IIT Delhi’s faculty, access to infrastructure and prototyping laboratories, IP search and filing services, guidance from Pfizer’s global experts, and access to venture capitalists and other industry linkages. For innovators who already have a ready proof of concept and are seeking to obtain a patent, the Program will provide access to IP attorneys and services and cover the patent fee.

The overarching objective of this Program is to nurture, support, celebrate and reward healthcare innovations that are Made in India. Aligning with the company’s ethos of bringing innovative solutions that significantly improve lives, ‘The Pfizer IIT-Delhi Innovation and IP Program’ is an example of an industry-academia collaboration that also supports the country’s national priority of ‘Creative India Innovative India’.

Pfizer’s funding through this program will be unencumbered. All rights on the innovations will be owned entirely by the innovators and they will be free to commercialize their patents as they desire.

S. Sridhar, Executive Director, Pfizer India said, “Pfizer promotes a culture of innovation and encourages this creative endeavour globally. Our Innovation and IP Program with IIT Delhi will promote, celebrate and reward innovations and advancements in healthcare that are born and brought up in India for the benefit of our people. In doing so, our effort aligns with the Government’s stated priority of creating a vibrant innovation ecosystem in the country and enhances the creation of intellectual property. I invite innovators in India to take advantage of this program and bring their healthcare inventions to life.”

Mr. Amitabh Kant, Secretary, Department of Industrial Policy and Promotion (DIPP), the Guest of Honour at the launch, said, “Nurturing entrepreneurship and innovation is a priority for India. In a knowledge economy, our success will be determined by the place we hold on the global innovation platform. I congratulate Pfizer and IIT Delhi on forging this partnership that will fuel indigenous innovations in the country. The Government is taking decisive steps to further enhance the innovation ecosystem in India and we welcome the participation of all stakeholders in this effort.”

The Foundation for Innovation and Technology Transfer is a well-established and recognized technology incubator that has been IIT Delhi’s industrial interface organization since 1992. FITT operates the incubation facilities on the campus through which a large number of successful innovations have been created and commercialized. FITT will implement all stages of the Pfizer IIT Delhi Innovation and IP Program – from inviting proposals, to reviewing, shortlisting and selecting innovators and awarding appropriate grants.

“IIT Delhi has a proud record of nurturing innovation and entrepreneurship. FITT and IIT Delhi have been the hotbed for innovations – helping entrepreneurs converts their ideas into intellectual property and successful business models. Through this partnership with Pfizer, we will provide access to resources and knowledge that would significantly increase the innovators’ chances of creating novel healthcare solutions and successful commercial enterprises,” said Dr. Anil Wali, Managing Director, Foundation of Innovation and Technology Transfer, IIT Delhi.

The Program will invite two rounds of proposals during the year 2015-2016. Call for proposals for the first round will open from November 27, 2015 until January 15, 2016. Applicants can submit their proposals on the FITT website. An independent panel of subject matter experts established by FITT will review and shortlist the potential incubatees. The Technology Business Incubator Unit board at IIT Delhi will make the final selection of individuals and start-ups that that shall receive the grants and be incubated at IIT Delhi.

About Pfizer Ltd:

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people. Every day, Pfizer colleagues work to advance wellness, prevention, treatments and cures that challenge the most feared diseases of  our time. Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 60 years in India, Pfizer has worked to make a difference for all who rely on us. To learn more about our
 commitments, please visit us at www.pfizerindia.com

About FITT:

FITT at IIT Delhi is an established and recognized technology incubator that has been in operation since 1992. Set up as an industrial interface organization at IIT Delhi, FITT works to foster, promote and sustain commercialization of Science and Technology in the Institute for mutual benefits. FITT is already recognized as an incubation partner by the BIRAC (Biotechnology Industry Research Assistance Council, a Govt. of India enterprise) and is a partner facility for their BIG scheme (Biotechnology Ignition Grant) - an initiative similar to the Pfizer-IIT Delhi Innovation and IP Programme.

About IIT Delhi:

Established in 1959, IIT-Delhi was declared an ‘Institution of National Importance’ in 1963. Ranked among India’s most prestigious centers of technology research, it aims to offer world standard instruction in applied science and engineering, provide facilities for specialized research, and to develop close cooperation with industry to solve live industrial problems.